Dual-energy CT for differentiating gastric gastrointestinal stromal tumors from leiomyomas

To evaluate the diagnostic value and reproducibility of quantitative dual-source dual-energy CT (dsDECT) parameters for differentiating 0.5–4.0 cm gastric GISTs from leiomyomas. This prospective study included patients with pathologically confirmed gastric GISTs (n = 61) or leiomyomas (n = 42) measuring 0.5–4.0 cm who underwent contrast-enhanced dsDECT between August 2025 and June 2026. Quantitative parameters, including IC, NIC, λHU, and Z, were compared between the two groups. Interobserver reproducibility was assessed using intraclass correlation coefficients (ICCs). Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis. Multivariable logistic regression was performed to determine whether VP IC remained independently associated with GIST after adjustment for relevant clinical and conventional imaging characteristics. VP parameters showed the most consistent discriminatory differences. VP IC, VP NIC, VP λHU, and VP Z were significantly higher in GISTs than in leiomyomas after false discovery rate correction. Among all evaluated dsDECT parameters, VP IC exhibited the highest diagnostic performance (AUC = 0.809; 95% CI, 0.723–0.894). At an optimal cutoff of 1.45 mg/mL, VP IC achieved an accuracy of 72.8%, a sensitivity of 62.3%, a specificity of 88.1%, and a positive predictive value of 88.4%. VP IC remained independently associated with GIST after adjustment for age, sex, CT maximum diameter, and growth pattern (adjusted odds ratio [aOR], 9.86; 95% CI, 3.73–33.65; P < 0.001). Interobserver agreement for VP IC was excellent (ICC, 0.962; 95% CI, 0.945–0.974). Addition of VP Z did not significantly improve discrimination compared with VP IC alone (AUC, 0.816 vs. 0.809; DeLong P = 0.510). Quantitative dsDECT parameters, VP IC provide reproducible noninvasive information for differentiating gastric GISTs from leiomyomas. VP IC showed moderate sensitivity and high specificity and remained independently associated with GIST after clinical adjustment. External validation is warranted before routine clinical implementation.

Authors

Publication Details

Journal
Scientific Reports
Published
2026-11-19
DOI
https://doi.org/10.1038/s41598-026-76023-9
Primary Topic
Gastrointestinal Tumor Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dual-energy CT for differentiating gastric gastrointestinal stromal tumors from leiomyomas

张玉忠, Linna Wu, Li-juan Wei, Si-wen Liu et al.
Scientific Reports
Gastrointestinal Tumor Research and Treatment
article

Dual-energy CT for differentiating gastric gastrointestinal stromal tumors from leiomyomas

张玉忠, Linna Wu, Li-juan Wei, Si-wen Liu, Xin Chen
article en

Abstract

To evaluate the diagnostic value and reproducibility of quantitative dual-source dual-energy CT (dsDECT) parameters for differentiating 0.5–4.0 cm gastric GISTs from leiomyomas. This prospective study included patients with pathologically confirmed gastric GISTs (n = 61) or leiomyomas (n = 42) measuring 0.5–4.0 cm who underwent contrast-enhanced dsDECT between August 2025 and June 2026. Quantitative parameters, including IC, NIC, λHU, and Z, were compared between the two groups. Interobserver reproducibility was assessed using intraclass correlation coefficients (ICCs). Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis. Multivariable logistic regression was performed to determine whether VP IC remained independently associated with GIST after adjustment for relevant clinical and conventional imaging characteristics. VP parameters showed the most consistent discriminatory differences. VP IC, VP NIC, VP λHU, and VP Z were significantly higher in GISTs than in leiomyomas after false discovery rate correction. Among all evaluated dsDECT parameters, VP IC exhibited the highest diagnostic performance (AUC = 0.809; 95% CI, 0.723–0.894). At an optimal cutoff of 1.45 mg/mL, VP IC achieved an accuracy of 72.8%, a sensitivity of 62.3%, a specificity of 88.1%, and a positive predictive value of 88.4%. VP IC remained independently associated with GIST after adjustment for age, sex, CT maximum diameter, and growth pattern (adjusted odds ratio [aOR], 9.86; 95% CI, 3.73–33.65; P < 0.001). Interobserver agreement for VP IC was excellent (ICC, 0.962; 95% CI, 0.945–0.974). Addition of VP Z did not significantly improve discrimination compared with VP IC alone (AUC, 0.816 vs. 0.809; DeLong P = 0.510). Quantitative dsDECT parameters, VP IC provide reproducible noninvasive information for differentiating gastric GISTs from leiomyomas. VP IC showed moderate sensitivity and high specificity and remained independently associated with GIST after clinical adjustment. External validation is warranted before routine clinical implementation.

Scientific Reports
Gastrointestinal Tumor Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon